BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bio-Rad Laboratories, Inc. (BIO) Purchases Medical Diagnostics Business From Provalis (PVLS)


9/7/2006 8:36:01 AM

HERCULES, CA--(MARKET WIRE)--Sep 7, 2006 -- Bio-Rad Laboratories, Inc. (AMEX:BIO - News) and (AMEX:BIO-B - News), a multinational manufacturer and distributor of life science research products and clinical diagnostics, announced today that it has completed the purchase of the medical diagnostics business of Provalis plc (London:PRO.L - News) for approximately $3 million in cash. Based in the United Kingdom, this business develops, manufactures, and sells point of care diagnostic products for chronic disease management of diabetes and osteoporosis. "Point of care testing continues to be of growing importance in the diagnostics area," said Norman Schwartz, Bio-Rad President and CEO. "While this is a relatively small acquisition, it expands our market breadth in the very critical area of diabetes monitoring."

About Bio-Rad

Bio-Rad Laboratories, Inc. (AMEX:BIO - News) and (AMEX:BIO-B - News) has remained at the center of scientific discovery for more than 50 years manufacturing and distributing a broad range of products for the life science research and clinical diagnostics markets. The company is renowned worldwide among hospitals, universities, major research institutions as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 75,000 research and industry customers worldwide through its global network of operations. The company employs over 5,000 people globally and had revenues of $1.1 billion in 2005. For more information, visit www.bio-rad.com.

Various statements made within this press release may constitute "forward-looking statements" for the purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. The forward-looking statements contained herein involve risks and uncertainties that could cause results to differ materially from the Company's expectation.

Contact: For more information, please contact: Tina Cuccia Corporate Communications Manager Bio-Rad Laboratories, Inc. 510-741-6063

Source: Bio-Rad Laboratories



Read at BioSpace.com

   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES